Mission Therapeutics
United KingdomEntry
2021
Hold
5yr
Status
Active
Who owns Mission Therapeutics?
Mission Therapeutics is a British Biotech company, currently owned by Rosetta Capital since 2021 and Sofinnova Partners.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Rosetta CapitalRosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below
Key facts
Ownership history
2 ownership periods · co-invest detected
Active
Co-invest · 2 holders · 2019 · present
Sofinnova PartnersActive
2019 · present(7yr) · Sofinnova Capital IX · 2018 · Life Sciences VC
Rosetta CapitalActive
2021 · present(5yr) · Rosetta Capital V · 2021 · Secondaries
More from Rosetta Capital V
Other portfolio companies in the same fund.
Ireland
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Mission Therapeutics?
Mission Therapeutics is currently owned by Rosetta Capital and Sofinnova Partners, through Rosetta Capital V, since 2021.
When did Rosetta Capital and 1 other acquire Mission Therapeutics?
Rosetta Capital and 1 other acquired Mission Therapeutics in 2021.
Who has owned Mission Therapeutics over time?
Mission Therapeutics has been through 2 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital IX · since 2019; Rosetta Capital · via Rosetta Capital V · since 2021.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue